(18)F-RGD PET/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment

BACKGROUND: The aim of this study was to evaluate (18)F-AlF-NOTA-PRGD2 positron emission tomography/computed tomography ((18)F-RGD PET/CT) and serum inflammation biomarkers for predicting outcomes of patients receiving combined antiangiogenic treatment for advanced non-small cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Wu, Leilei, Liu, Zhiguo, Seery, Samuel, Li, Jianing, Gao, Zhenhua, Yu, Jinming, Meng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212050/
https://www.ncbi.nlm.nih.gov/pubmed/34150635
http://dx.doi.org/10.3389/fonc.2021.671912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212050/
https://www.ncbi.nlm.nih.gov/pubmed/34150635
http://dx.doi.org/10.3389/fonc.2021.671912

Ejemplares similares